Matsuoka K - Search Results

1

Efficacy and Safety of Etrasimod in Patients with Ulcerative Colitis in Japan: Data from the Phase 3 ELEVATE UC 12 and ELEVATE UC 40 JAPAN Trials.

Takeuchi K, Hisamatsu T, Nakase H, Matsuoka K, Keating M, Yuasa H, Oe M, Arai S, Mazur R, Hibi T. Takeuchi K, et al. Among authors: matsuoka k. Digestion. 2024 Sep 24:1-9. doi: 10.1159/000541383. Online ahead of print. Digestion. 2024. PMID: 39317165 Free article.

2

[Ulcerative colitis and Crohn's disease].

Matsuoka K, Hibi T. Matsuoka K, et al. Nihon Rinsho. 2005 May;63 Suppl 5:507-11. Nihon Rinsho. 2005. PMID: 15954400 Review. Japanese. No abstract available.

3

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, Sato T, Inoue N, Ogata H, Hibi T. Matsuoka K, et al. Am J Gastroenterol. 2007 Feb;102(2):331-7. doi: 10.1111/j.1572-0241.2006.00989.x. Epub 2006 Dec 11. Am J Gastroenterol. 2007. PMID: 17156136

4

[Viral infection of the small intestine].

Matsuoka K, Hibi T. Matsuoka K, et al. Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):65-70. doi: 10.2169/naika.100.65. Nihon Naika Gakkai Zasshi. 2011. PMID: 21387636 Japanese. No abstract available.

5

[Mechanism and therapeutic strategy of second failure of infliximab treatment for Crohn's disease].

Kanai T, Matsuoka K, Hisamatsu T, Iwao Y, Ogata H, Hibi T. Kanai T, et al. Among authors: matsuoka k. Nihon Shokakibyo Gakkai Zasshi. 2012 Mar;109(3):364-9. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 22398900 Review. Japanese. No abstract available.

6

Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.

Sakuraba A, Sato T, Morohoshi Y, Matsuoka K, Okamoto S, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T. Sakuraba A, et al. Among authors: matsuoka k. Ther Apher Dial. 2012 Jun;16(3):213-8. doi: 10.1111/j.1744-9987.2012.01064.x. Epub 2012 Apr 2. Ther Apher Dial. 2012. PMID: 22607563 Clinical Trial.

7

Long-term prognosis of patients with ulcerative colitis treated with cytapheresis therapy.

Takayama T, Kanai T, Matsuoka K, Okamoto S, Sujino T, Mikami Y, Hisamatsu T, Yajima T, Iwao Y, Ogata H, Hibi T. Takayama T, et al. Among authors: matsuoka k. J Crohns Colitis. 2013 Mar;7(2):e49-54. doi: 10.1016/j.crohns.2012.05.005. Epub 2012 May 26. J Crohns Colitis. 2013. PMID: 22633997

8

Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.

Uo M, Hisamatsu T, Miyoshi J, Kaito D, Yoneno K, Kitazume MT, Mori M, Sugita A, Koganei K, Matsuoka K, Kanai T, Hibi T. Uo M, et al. Among authors: matsuoka k. Gut. 2013 Dec;62(12):1734-44. doi: 10.1136/gutjnl-2012-303063. Epub 2012 Sep 26. Gut. 2013. PMID: 23013725

9

Immune aspects of the pathogenesis of inflammatory bowel disease.

Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K, Hibi T. Hisamatsu T, et al. Among authors: matsuoka k. Pharmacol Ther. 2013 Mar;137(3):283-97. doi: 10.1016/j.pharmthera.2012.10.008. Epub 2012 Oct 26. Pharmacol Ther. 2013. PMID: 23103332 Review.

10

[Anti-viral therapy for ulcerative colitis complicated with cytomegalovirus colitis].

Matsuoka K, Hibi T. Matsuoka K, et al. Nihon Rinsho. 2012 Feb;70 Suppl 1:387-9. Nihon Rinsho. 2012. PMID: 23126123 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,674 results

Search Page

Filters